Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis

Low-dose computed tomography (LDCT) is predominantly applied in lung cancer screening programs. Tobacco smoking is the main risk factor for developing lung cancer but is also common for cardiovascular diseases, including aortic stenosis (AS). Consequently, an increased prevalence of cardiovascular d...

Full description

Bibliographic Details
Main Authors: Kaja Klein-Awerjanow, Witold Rzyman, Robert Dziedzic, Jadwiga Fijalkowska, Piotr Spychalski, Edyta Szurowska, Marcin Fijalkowski
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/2/246
_version_ 1797443866648903680
author Kaja Klein-Awerjanow
Witold Rzyman
Robert Dziedzic
Jadwiga Fijalkowska
Piotr Spychalski
Edyta Szurowska
Marcin Fijalkowski
author_facet Kaja Klein-Awerjanow
Witold Rzyman
Robert Dziedzic
Jadwiga Fijalkowska
Piotr Spychalski
Edyta Szurowska
Marcin Fijalkowski
author_sort Kaja Klein-Awerjanow
collection DOAJ
description Low-dose computed tomography (LDCT) is predominantly applied in lung cancer screening programs. Tobacco smoking is the main risk factor for developing lung cancer but is also common for cardiovascular diseases, including aortic stenosis (AS). Consequently, an increased prevalence of cardiovascular diseases is expected in lung cancer screenees. Therefore, initial aortic valve calcification evaluation should be additionally performed on LDCT. The aim of this study was to estimate a calcium score (CS) cutoff point for clinically significant AS diagnosis based on LDCT, confirmed by echocardiographic examination. The study included 6631 heavy smokers who participated in a lung cancer screening program (MOLTEST BIS). LDCTs were performed on all individuals and were additionally assessed for aortic valve calcification with the use of CS according to the Agatston method. Patients with CS ≥ 900 were referred for echocardiography to confirm the diagnosis of AS and to evaluate its severity. Of 6631 individuals, 54 met the inclusion criteria and underwent echocardiography for confirmation and assessment of AS. Based on that data, receiver operating characteristic (ROC) curves of CS were plotted, and cutoff points for clinically significant AS diagnosis were established: A CS of 1758 for at least moderate AS had 85.71% (CI 65.36–95.02%) sensitivity and 75.76% (CI 58.98–87.17%) specificity; a CS of 2665 for severe AS had 87.5% (CI 73.89–94.54%) sensitivity and 76.92% (CI 49.74–91.82%) specificity. This is the first study to assess possible CS cutoff points for diagnosing clinically significant AS detected by LDCT in lung cancer screening participants. LDCT with CS assessment could enable early detection of patients with clinically significant AS and therefore identify patients who require appropriate treatment.
first_indexed 2024-03-09T13:03:16Z
format Article
id doaj.art-ed8a8a24260b49f4919ecc6ecaa8f2d0
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T13:03:16Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-ed8a8a24260b49f4919ecc6ecaa8f2d02023-11-30T21:52:02ZengMDPI AGDiagnostics2075-44182023-01-0113224610.3390/diagnostics13020246Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional AnalysisKaja Klein-Awerjanow0Witold Rzyman1Robert Dziedzic2Jadwiga Fijalkowska3Piotr Spychalski4Edyta Szurowska5Marcin Fijalkowski6Second Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, PolandDepartment of Thoracic Surgery, Medical University of Gdansk, 80-210 Gdansk, PolandDepartment of Thoracic Surgery, Medical University of Gdansk, 80-210 Gdansk, PolandSecond Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, PolandDepartment of General, Endocrine and Transplant Surgery, Medical University of Gdansk, 80-210 Gdansk, PolandSecond Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, PolandFirst Department of Cardiology, Medical University of Gdansk, 80-210 Gdansk, PolandLow-dose computed tomography (LDCT) is predominantly applied in lung cancer screening programs. Tobacco smoking is the main risk factor for developing lung cancer but is also common for cardiovascular diseases, including aortic stenosis (AS). Consequently, an increased prevalence of cardiovascular diseases is expected in lung cancer screenees. Therefore, initial aortic valve calcification evaluation should be additionally performed on LDCT. The aim of this study was to estimate a calcium score (CS) cutoff point for clinically significant AS diagnosis based on LDCT, confirmed by echocardiographic examination. The study included 6631 heavy smokers who participated in a lung cancer screening program (MOLTEST BIS). LDCTs were performed on all individuals and were additionally assessed for aortic valve calcification with the use of CS according to the Agatston method. Patients with CS ≥ 900 were referred for echocardiography to confirm the diagnosis of AS and to evaluate its severity. Of 6631 individuals, 54 met the inclusion criteria and underwent echocardiography for confirmation and assessment of AS. Based on that data, receiver operating characteristic (ROC) curves of CS were plotted, and cutoff points for clinically significant AS diagnosis were established: A CS of 1758 for at least moderate AS had 85.71% (CI 65.36–95.02%) sensitivity and 75.76% (CI 58.98–87.17%) specificity; a CS of 2665 for severe AS had 87.5% (CI 73.89–94.54%) sensitivity and 76.92% (CI 49.74–91.82%) specificity. This is the first study to assess possible CS cutoff points for diagnosing clinically significant AS detected by LDCT in lung cancer screening participants. LDCT with CS assessment could enable early detection of patients with clinically significant AS and therefore identify patients who require appropriate treatment.https://www.mdpi.com/2075-4418/13/2/246low-dose computed tomographyLDCTlung cancer screeningscreeningaortic valve stenosisAS
spellingShingle Kaja Klein-Awerjanow
Witold Rzyman
Robert Dziedzic
Jadwiga Fijalkowska
Piotr Spychalski
Edyta Szurowska
Marcin Fijalkowski
Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
Diagnostics
low-dose computed tomography
LDCT
lung cancer screening
screening
aortic valve stenosis
AS
title Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
title_full Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
title_fullStr Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
title_full_unstemmed Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
title_short Assessment of Calcium Score Cutoff Point for Clinically Significant Aortic Stenosis on Lung Cancer Screening Program Low-Dose Computed Tomography—A Cross-Sectional Analysis
title_sort assessment of calcium score cutoff point for clinically significant aortic stenosis on lung cancer screening program low dose computed tomography a cross sectional analysis
topic low-dose computed tomography
LDCT
lung cancer screening
screening
aortic valve stenosis
AS
url https://www.mdpi.com/2075-4418/13/2/246
work_keys_str_mv AT kajakleinawerjanow assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT witoldrzyman assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT robertdziedzic assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT jadwigafijalkowska assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT piotrspychalski assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT edytaszurowska assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis
AT marcinfijalkowski assessmentofcalciumscorecutoffpointforclinicallysignificantaorticstenosisonlungcancerscreeningprogramlowdosecomputedtomographyacrosssectionalanalysis